Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -4.679.11-34.6021.3433.82

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is -4.67 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34
Mar202133.82

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34
-36.90
Mar2021 33.82 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,213.8 Cr 8.2% 4.9% 2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,469.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹160,672.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹125,034.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,542.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,571.0 Cr 5.3% 7.9% -2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8.2%

4.9%

2%

SENSEX

1.2%

1.9%

-0.2%


You may also like the below Video Courses